Anna Leblond, MBA, has extensive experience in clinical research and development within the biopharmaceutical sector. Key positions include Development Scientist at Cytonet LLC, where Anna led strategic project planning and execution for a second-generation cell therapy product, and Clinical Trial Manager at ImmunityBio. Prior roles encompassed Clinical Research Associate and Clinical Research Associate II at DOCS, where Anna demonstrated expertise in on-site and remote monitoring across various study types. Currently, Anna serves as Clinical Study Manager at both G1 Therapeutics, Inc. and Liquidia Corporation. Anna holds a Master of Business Administration in BioSciences Management from North Carolina State University and a Bachelor's Degree in Biochemistry with Honors from the University of Nevada-Reno.
This person is not in the org chart
This person is not in any teams
This person is not in any offices